Market Tracker

10/24 6:05pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.03
Data as of Oct 24
 +0.04 / +0.80%
Today’s Change
3.81
Today|||52-Week Range
7.73
-17.13%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close4.99
Today’s open5.01
Day’s range4.88 - 5.05
Volume22,955
Average volume (3 months)91,763
Market cap$178.1M
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
THLDThreshold Pharmaceut...+0.03+1.01%
ELTPElite Pharmaceutical...+0.01+3.52%
ZGNXZogenix Inc+0.01+0.79%
OHRPOHR Pharmaceutical I...0.000.00%
Data as of 3:59pm ET, 10/24/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts